NINTEDANIB VIATRIS 150 mg, capsule molle — 60 plaquettes aluminium de 1 capsule, (dose unitaire)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930325254
  • CIP7 3032525
  • CIS 68781324
  • Registration number EU/1/25/1959

What the source publishes

Holder
VIATRIS (IRLANDE)
Active ingredients
NINTÉDANIB, ÉSILATE DE NINTÉDANIB
Form
capsule molle
Package
60 plaquettes aluminium de 1 capsule, (dose unitaire)
Routes
orale
Administrative status
authorised
Supply regime
prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription hospitalière ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2025-08-22
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930325254
{
  "cis": "68781324",
  "cip7": "3032525",
  "form": "capsule molle",
  "name": "NINTEDANIB VIATRIS 150 mg, capsule molle — 60 plaquettes aluminium de 1 capsule, (dose unitaire)",
  "cip13": "3400930325254",
  "holder": "VIATRIS (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "VIATRIS (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "608.16",
  "authorisedOn": "2025-08-22",
  "compositions": [
    {
      "name": "NINTÉDANIB",
      "nature": "FT",
      "strength": "150 mg",
      "linkageNumber": "1",
      "substanceCode": "41187",
      "dosageReference": "une capsule",
      "pharmaceuticalElement": "capsule"
    },
    {
      "name": "ÉSILATE DE NINTÉDANIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "52826",
      "dosageReference": null,
      "pharmaceuticalElement": "capsule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription réservée aux spécialistes et services PEDIATRIE ; médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services MEDECINE INTERNE ; prescription réservée aux spécialistes et services PNEUMOLOGIE ; prescription réservée aux spécialistes et services RHUMATOLOGIE ; prescription hospitalière ; liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "607.14",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "NINTEDANIB VIATRIS 150 mg, capsule molle",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "60 plaquettes aluminium de 1 capsule, (dose unitaire)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30%"
  ],
  "marketingDeclaredOn": "2026-04-10",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "NINTÉDANIB",
    "ÉSILATE DE NINTÉDANIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription réservée aux spécialistes et services PEDIATRIE",
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services MEDECINE INTERNE",
    "prescription réservée aux spécialistes et services PNEUMOLOGIE",
    "prescription réservée aux spécialistes et services RHUMATOLOGIE",
    "prescription hospitalière",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/25/1959",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930325254"